Abstract
The prevalence of benzene rings in pharmaceutical scaffolds has prompted efforts to identify structural bioisosteres with improved in vivo properties. Notably, investigators have leveraged bicyclo[1.1.1]pentanes (BCPs)—C(sp3)-enriched, 1,4-disubstituted phenyl bioisosteres—to tune the pharmacokinetic profiles of lead compounds. Although 3-arylated BCPs have been widely implemented to confer resistance to oxidative degradation and hydrogen atom transfer (HAT) processes, the analogous 3-alkylated BCPs remain underexplored as bioisosteric “benzylic” C–H motifs. Current methods for installing 3-alkylated BCP motifs are heavily reliant on lengthy de novo synthesis and the preparation of reactive [1.1.1]propellane feedstocks, limiting their adoption in drug-discovery programs. In this report, we disclose a mild, unified method for the preparation of both alkyl- and aryl-substituted BCPs from bench-stable precursors. This method, which proceeds via dual copper-photoredox catalysis, is capable of installing BCP functionalities onto a range of saturated motifs, aryl-containing residues, and medicinally relevant heterocycles.
Original language | English (US) |
---|---|
Article number | 102537 |
Journal | Chem |
Volume | 11 |
Issue number | 5 |
DOIs | |
State | Published - May 8 2025 |
All Science Journal Classification (ASJC) codes
- General Chemistry
- Biochemistry
- Environmental Chemistry
- General Chemical Engineering
- Biochemistry, medical
- Materials Chemistry
Keywords
- SDG3: Good health and well-being
- SDG9: Industry, innovation, and infrastructure
- bicyclo[1.1.1]pentane organobromide activation
- bioisostere
- copper catalysis
- halogen abstraction
- photoredox
- reaction modularity